The trademark application DELIVERING CURE was filed by Amsterdam Molecular Therapeutics (AMT) Holding N.V., a corporation established under the laws of the Kingdom of the Netherlands (the "Applicant"). Application refused.
The application was filed in English (Spanish was selected as the second language).
Change of name and professional address of the trademark registration was recorded on December 14, 2008.
The Refusal with reference B 006852917 was Rejected according to Article 7(1)(b) CTMR with decision issued on June 11, 2009 by the EUIPO.
Goods And Services
The mark was filed in class 5 with following description of goods:
Pharmaceutical products
Biological preparations for use in medical and clinical gene therapy and cell therapy
Clinical medical reagents for use in gene therapy, gene diagnosis, and gene testing
Pharmaceutical preparations
Vaccines for use in gene therapy
Gene therapy and prophylaxis products.
The mark was filed in class 44 with Gene delivery, gene transfer, gene regulation and gene modulation for the treatment of metabolic disorders, ocular disorders, diseases of the nervous system, blood disorders, cancer, inflammatory and auto-immune diseases, vascular disorders, and single gene disorders.